Stockholders' Equity (Tables)

12 Months Ended

Jul. 31, 2025

Stockholders' Equity Note [Abstract]

Schedule of Capital Stock

Information as to the Company’s capital stock as of July 31, 2025 and 2024 was as follows:

	July 31, 2025				July 31, 2024
	Shares Authorized	Shares Issued	Amount (thousands)		Shares Authorized	Shares Issued	Amount (thousands)
Preferred Stock, $.01 par value	5,000,000				5,000,000
Cumulative Preferred Stock: 6% Cumulative	5,000				5,000
1972 Series	10,000				10,000
1979 Series	30,000				30,000
Common Stock, $.01 par value: Class A Nonvoting	100,000,000	51,261,487	$	513	100,000,000	51,261,487	$	513
Class B Voting	10,000,000	3,538,628	35		10,000,000	3,538,628	35
			$	548			$	548

Schedule of Other Activity in Stockholders' Equity

The following is a summary of other activity in stockholders’ equity during the years ended July 31, 2025, 2024, and 2023:

	Deferred Compensation		Shares Held in Rabbi Trust, at cost		Total
Balances at July 31, 2022	$	11,055	$	(11,055)	$	—
Shares at July 31, 2022	318,285		318,285
Sale of shares at cost	$	(739)	$	739	$	—
Purchase of shares at cost	1,067		(1,067)		—
Balances at July 31, 2023	$	11,383	$	(11,383)	$	—
Shares at July 31, 2023	318,198		318,198
Sale of shares at cost	$	(889)	$	889	$	—
Purchase of shares at cost	1,217		(1,217)		—
Balances at July 31, 2024	$	11,711	$	(11,711)	$	—
Shares at July 31, 2024	312,124		312,124
Sale of shares at cost	$	(556)	$	556	$	—
Purchase of shares at cost	1,384		(1,384)		—
Balances at July 31, 2025	$	12,539	$	(12,539)	$	—
Shares at July 31, 2025	313,467		313,467

Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions

The weighted-average assumptions used in the Black-Scholes valuation model are reflected in the following table:

Black-Scholes Option Valuation Assumptions	2024		2023
Expected term (in years)	5.40		5.71
Expected volatility	30.23	%	29.64	%
Expected dividend yield	1.89	%	2.01	%
Risk-free interest rate	4.72	%	3.66	%

Schedule of Stock Option Activity

The following is a summary of stock option activity for the year ended July 31, 2025:

Time-Based Options	Options Outstanding	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)	Aggregate Intrinsic Value
Outstanding as of July 31, 2024	1,222,046	$	44.46
Granted	—	—
Exercised	(159,713)	39.37
Forfeited	(10,019)	51.08
Outstanding as of July 31, 2025	1,052,314	$	45.17	4.6	$	26,585
Exercisable as of July 31, 2025	1,001,583	$	44.98	4.5	$	25,497

The following table summarizes additional stock option information:

	2025		2024		2023
Weighted-average fair value of options granted during the period	$	—	$	16.41	$	12.14
Intrinsic value of options exercised during the period (in thousands)	5,559		8,860		1,822
Fair value of options vested during the period (in thousands)	1,529		2,020		3,384
Cash received from the exercise of stock options during the period (in thousands)	6,171		8,186		4,091
Tax benefit on options exercised during the period (in thousands)	1,390		2,215		455

Schedule of RSU Activity

The following tables summarize the RSU activity during the year ended July 31, 2025:

RSUs	Shares	Weighted Average Grant Date  Fair Value
Non-vested RSUs as of July 31, 2024	148,991	$	52.20
Granted	96,322	74.35
Vested	(72,979)	50.96
Forfeited	(9,667)	63.69
Non-vested RSUs as of July 31, 2025	162,667	$	65.19

Schedule of PRSU Activity

The following tables summarize the PRSU activity during the year ended July 31, 2025:

PRSUs	Shares	Weighted Average Grant Date  Fair Value
Non-vested PRSUs as of July 31, 2024	103,221	$	53.46
Granted	61,981	71.24
Vested	(8,098)	64.44
Forfeited	(4,838)	58.80
Non-vested PRSUs as of July 31, 2025	152,266	$	59.92